Novartis AG (NVSEF)
OTCMKTS
· Delayed Price · Currency is USD
115.32
-0.40 (-0.34%)
Jun 4, 2025, 1:34 PM EDT
Novartis AG Employees
Novartis AG had 75,883 employees as of December 31, 2024. The number of employees decreased by 174 or -0.23% compared to the previous year.
Employees
75,883
Change (1Y)
-174
Growth (1Y)
-0.23%
Revenue / Employee
$701,369
Profits / Employee
$169,458
Market Cap
230.96B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 75,883 | -174 | -0.23% |
Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Novartis AG News
- 3 days ago - Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug - Benzinga
- 4 days ago - Novartis' Pluvicto shown to slow prostate cancer in earlier setting - Reuters
- 4 days ago - Novartis's Cancer Treatment Pluvicto Shows Positive Results in Trial - WSJ
- 4 days ago - Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer - GlobeNewsWire
- 7 days ago - Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Benzinga
- 9 days ago - Novartis announces commencement of tender offer to acquire Regulus Therapeutics - GlobeNewsWire
- 16 days ago - If I Could Only Buy 2 Dividend Stocks Right Now (May 2025 Edition) - Seeking Alpha
- 21 days ago - New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline - GlobeNewsWire